Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
B. Berger, G. Stenström, G. Sundkvist. (2000) Random C-peptide in the classification of diabetes. Scandinavian Journal of Clinical and Laboratory Investigation 60:8, pages 687-693.
Read now
Read now
A. Gottsäter, M. Landin-Olsson, P. Fernlund, B. Gullberg, Å. Lernmark & G. Sundkvist. (1992) Pancreatic beta-cell function evaluated by intravenous glucose and glucagon stimulation. A comparison between insulin and C-peptide to measure insulin secretion. Scandinavian Journal of Clinical and Laboratory Investigation 52:7, pages 631-639.
Read now
Read now
Articles from other publishers (26)
Sajid Iqbal, Abdulrahim Abu Jayyab, Ayah Mohammad Alrashdi & Silvia Reverté-Villarroya. (2023) The Predictive Ability of C-Peptide in Distinguishing Type 1 Diabetes From Type 2 Diabetes: A Systematic Review and Meta-Analysis. Endocrine Practice 29:5, pages 379-387.
Crossref
Crossref
Rana Irilouzadian, Siamak Afaghi, Farzad Esmaeili Tarki, Fatemehsadat Rahimi & Nasser Malekpour Alamadari. (2023)
Urinary c‐peptide creatinine ratio (
UCPCR
) as a predictor of coronary artery disease in type 1 diabetes mellitus
. Endocrinology, Diabetes & Metabolism 6:3.
Crossref
Crossref
Maria João Meneses, Rita Susana Patarrão, Tomás Pinheiro, Inês Coelho, Nuno Carriço, Ana Carolina Marques, Artur Romão, João Nabais, Elvira Fortunato, João Filipe Raposo & Maria Paula Macedo. (2022) Leveraging the future of diagnosis and management of diabetes: From old indexes to new technologies. European Journal of Clinical Investigation 53:4.
Crossref
Crossref
Wan Zhou, Jie Li, Xiaojing Yuan, Wei Wang, Huanran Zhou, Haoqiang Zhang & Shandong Ye. (2022) Application of urine C-peptide creatinine ratio in type 2 diabetic patients with different levels of renal function. Frontiers in Endocrinology 13.
Crossref
Crossref
T. J. McDonald & M. H. Perry. 2016. Type-1 Diabetes. Type-1 Diabetes
93
102
.
Minoru Iwata, Yumi Matsushita, Kazuhito Fukuda, Tatsurou Wakura, Keisuke Okabe, Yukiko Koshimizu, Yasuo Fukushima, Chikaaki Kobashi, Yu Yamazaki, Hisae Honoki, Hikari Suzuki, Mika Kigawa & Kazuyuki Tobe. (2014) Secretory units of islets in transplantation index is a useful predictor of insulin requirement in Japanese type 2 diabetic patients. Journal of Diabetes Investigation 5:5, pages 570-580.
Crossref
Crossref
A. G. Jones & A. T. Hattersley. (2013) The clinical utility of C‐peptide measurement in the care of patients with diabetes. Diabetic Medicine 30:7, pages 803-817.
Crossref
Crossref
Tomoyasu Fukui, Kayoko Oono, Noriko Hara, Takeshi Yamamoto, Masaharu Nagashima, Hirokuni Naito & Tsutomu Hirano. (2013) Increment of C-peptide after glucagon injection determines the progressive nature of Japanese type 2 diabetes: A long-term follow-up study. Endocrine Journal 60:6, pages 715-724.
Crossref
Crossref
Penny Clark & Tim McDonald. 2013. The Immunoassay Handbook. The Immunoassay Handbook
783
794
.
Angus G Jones, Rachel EJ Besser, Beverley M Shields, Timothy J McDonald, Suzy V Hope, Bridget A Knight & Andrew T Hattersley. (2012) Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin. BMC Endocrine Disorders 12:1.
Crossref
Crossref
B. M. Shields, T. J. McDonald, S. Ellard, M. J. Campbell, C. Hyde & A. T. Hattersley. (2012) The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia 55:5, pages 1265-1272.
Crossref
Crossref
P. Bowman, T. J. McDonald, B. M. Shields, B. A. Knight & A. T. Hattersley. (2012) Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetes. Diabetic Medicine 29:1, pages 90-93.
Crossref
Crossref
A. G. Jones, R. E. J. Besser, T. J. McDonald, B. M. Shields, S. V. Hope, P. Bowman, R. A. Oram, B. A. Knight & A. T. Hattersley. (2011) Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes. Diabetic Medicine 28:9, pages 1034-1038.
Crossref
Crossref
Rachel E.J. BesserJohnny Ludvigsson, Angus G. JonesTimothy J. McDonaldBeverley M. ShieldsBridget A. KnightAndrew T. Hattersley. (2011) Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 Diabetes. Diabetes Care 34:3, pages 607-609.
Crossref
Crossref
Tim J McDonald, Bridget A Knight, Beverley M Shields, Pamela Bowman, Maurice B Salzmann & Andrew T Hattersley. (2009) Stability and Reproducibility of a Single-Sample Urinary C-Peptide/Creatinine Ratio and Its Correlation with 24-h Urinary C-Peptide. Clinical Chemistry 55:11, pages 2035-2039.
Crossref
Crossref
J Permert, I Ihse, L Jorfeldt, H von Schenck, H J Arnquist & J Larsson. (1993) Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. British Journal of Surgery 80:8, pages 1047-1050.
Crossref
Crossref
Adrian M.C. Covic, Jeffrey R. Schelling, Marigel Constantiner, Sudha K. Iyengar & John R. Sedor. (2000) Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients. Kidney International 58:4, pages 1742-1750.
Crossref
Crossref
Matthew C. Riddle. (1999) Insulin or Pills for Diabetes? How Should We Decide?. Endocrine Practice 5:3, pages 159-161.
Crossref
Crossref
M. N. Elbagir, M. N. Elbagir, M. A. Eltom & C. Berne. (2004) Classification of newly‐onset IDDIM and NIDDIM in subjects aged 25–45 years in Sudan. Journal of Internal Medicine 244:6, pages 443-450.
Crossref
Crossref
A. J. Scheen. 1996. Glucagon III. Glucagon III
211
222
.
Mary Jane Prior, Thaddeus Prout, Dayton Miller, Robin Ewart & Dinesh Kumar. (1993) C-peptide and the classification of diabetes mellitus patients in the Early treatment diabetic retinopathy study report number 6. Annals of Epidemiology 3:1, pages 9-17.
Crossref
Crossref
I. Nosari, G. Lepore, M. L. Maglio, F. Cortinovis & G. Pagani. (2014) The effect of various blood glucose levels on post-glucagon C-peptide secretion in type 2 (non insulin-dependent) diabetes. Journal of Endocrinological Investigation 15:2, pages 143-146.
Crossref
Crossref
M. Landin-Olsson, K. O. Nilsson, �. Lernmark & G. Sundkvist. (1990) Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus. Diabetologia 33:9, pages 561-568.
Crossref
Crossref
H. J. Gjessing, B. Reinholdt & O. Pedersen. (1989) The plasma C-peptide and insulin responses to stimulation with intravenous glucagon and a mixed meal in well-controlled Type 2 (non-insulin-dependent) diabetes mellitus: dependency on acutely established hyperglycaemia. Diabetologia 32:12, pages 858-863.
Crossref
Crossref
H. J. Gjessing, L. E. Matzen, O. K. Faber & A. Fr�land. (1989) Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes. Diabetologia 32:5, pages 305-311.
Crossref
Crossref
N.‐P. HUTTUNEN, M. KNIP, M.‐L. KÄÄR, R. PUUKKA & H. K. ÅKERBLOM. (2008) Clinical Significance of Urinary C‐Peptide Excretion in Children with Insulin‐Dependent Diabetes Mellitus. Acta Paediatrica 78:2, pages 271-277.
Crossref
Crossref